LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint Read more
UCB announces BRIVIACT (brivaracetam) now approved by FDA to treat partial-onset (focal) seizures in pediatric epilepsy patients Read more
Novartis announces FDA approval of Gilenya as the first disease-modifying therapy for pediatric relapsing multiple sclerosis Read more
miRagen Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides Read more
Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome Read more